Cutaneous lymphoma and ultraviolet radiation
Ultraviolet Radiation and Cutaneous Lymphoma
Sample size: 827
publication
Author Information
Author(s): Hershel Zackheim
Primary Institution: University of California at San Francisco
Hypothesis
The immunosuppressive effect of ultraviolet radiation may contribute to the development of cutaneous lymphoma.
Conclusion
The study highlights the effectiveness of UV-B in treating early stage cutaneous T-cell lymphoma, particularly mycosis fungoides.
Supporting Evidence
- UV-B is well documented as effective in treating early stage cutaneous T-cell lymphoma.
- The incidence of cutaneous lymphoma in the EORTC registry was four times more frequent for CTCL than for cutaneous B-cell lymphoma.
- Approximately 5-6% of registered patients at the University of California clinic had non-MF type cutaneous lymphoma.
Takeaway
Ultraviolet light can help treat a type of skin cancer called cutaneous T-cell lymphoma, especially in its early stages.
Limitations
The comparison of data from different studies requires careful qualification due to differences in definitions and populations.
Participant Demographics
The study involved patients with cutaneous lymphoma, including both mycosis fungoides and non-mycotic types.
Want to read the original?
Access the complete publication on the publisher's website